We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Details and statistics on the import of unlicensed medicines from March 2014 onwards.
The number of applications pending, refused and granted for the early access to medicines scheme (EAMS).
Expected time taken to process and grant a marketing authorisation or a variation to a marketing authorisation.
This PAR covers the assessment of an application to reclassify Nasacort Allergy Relief for Adults 55 micrograms/dose, nasal spray, suspension from Pharmacy (P) medicine to General Sales List.
This PAR covers the assessment of an application to reclassify Almerg 180mg film-coated tablets from Prescription Only Medicine (POM) to Pharmacy (P) medicine.
This PAR covers the assessment of an application to reclassify Allevia 120mg tablets from Prescription Only Medicine (POM) to General Sales List (GSL).
This PAR covers the assessment of an application to reclassify Benacort Hayfever Relief for Adults 64 micrograms, nasal spray from Prescription Only Medicine (POM) to General Sales (GSL).
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).